Patient is prescribed lifelong anticoagulation

Lifelong anticoagulation is recommended in patients with CTEPH but no data exist on the efficacy and safety of new direct oral

anticoagulants.

Patient may suffer new thromboembolic event and deteriorate further.

This is a wrong response that could lead to potentially harmful results to the health.